" class="no-js "lang="en-US"> Abbott Archives - Medtech Alert
Wednesday, June 19, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms

Stereotaxis today announced a global collaboration with Abbott to integrate Abbott’s EnSite™ X EP System […]

Abbott Announces US and European Approvals for New Technologies to Support Effective Treatment for Abnormal Heart Rhythms

Abbott has announced two approvals as part of its growing suite of electrophysiology products in […]

Abbott Announces Development of Novel Continuous Glucose-Ketone Monitoring System

Abbott (NYSE: ABT) today announced it’s developing a new biowearable that will continuously monitor glucose and […]

New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies

Abbott (NYSE: ABT) today announced two late-breaking data presentations highlighting both TriClip™, a first-of-its kind minimally […]

Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise

Abbott (NYSE: ABT) announced today it has received FDA clearance for its Alinity™ m STI Assay. […]

Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with Diabetes

Abbott (NYSE: ABT), CamDiab and Ypsomed today announced that they are partnering to develop and commercialize […]

Abbott Strengthens Its Connected Care Technologies with Latest Neurosphere™ Mypath™ Digital Health App

Abbott (NYSE: ABT) today announced that it has launched an upgraded version of its NeuroSphere™ […]

Abbott Senior Medical Director joins Nutromics as inaugural Chief Medical Officer

Australian and US MedTech start-up Nutromics (Nutromics or the Company), a global leader in DNA-based […]

Abbott Receives FDA Approval for Aveir™ Vr Leadless Pacemaker System to Treat Patients with Slow Heart Rhythms

Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved […]

Abbott's CardioMEMS™ HF System Receives FDA Approval to Support Patients Battling Earlier-stage Heart Failure

Abbott today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more